Advancing Voluntary, Informed Consent to Medical Intervention
Christopher Exley, PhD, Professor
Christopher Exley, PhD, Professor in Bioinorganic Chemistry at Keele University, and Leader of the Research Group on Aluminium and Silicon, He is a Fellow of the Royal Society of Biology (FRSB), Scientific Member of the British Society of Ecological Medicine (BSEM).
Dr. Exley is recognized as a world-renowned expert on Aluminum toxicity and aluminum in the human brain. His research has been published in approximately 190 peer-reviewed journals. He has authored twelve chapters in books, and edited compilations on aluminium : aluminium in biological systems, aluminium in medicine, aluminium in Alzheimer’s disease, and aluminium in the human brain.
Dr. Exley’s publications are listed here. Dr. Exley’s most recent journal articles include:
“Currently about 20 childhood vaccines include an aluminium adjuvant. The aluminium salt is the major component of a vaccine (after water) and its high content is why vaccine preparations are invariably cloudy in appearance . As an example, GlaxoSmithKline’s Infanrix Hexa vaccine is reported by the manufacturer to contain 0.82 mg of aluminium per vaccine (0.5 mL). Thus, the weight of aluminium salt in this vaccine is approximately 8 mg, which is approximately ten times the weight of all of the other components of the vaccine when combined. An aluminium-adjuvanted vaccine is essentially a very high concentration of an aluminium salt.”